Get App Open
In App
Check
Credit Score
Open App
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 28, 12:22
5601.15
97 (1.76%)
VOLUME 8,027
LIVE
NSE
Jul 28, 12:22
5599.70
92.7 (1.68%)
VOLUME 387,752
News on Dr Reddys Laboratories
Select Year: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's rises to 52-week high as Q1 earnings top estimate; brokerages positive but valuations a sore point

11.43 am | 27 Jul 2023 |  Source: Moneycontrol.com

Dr Reddy's topline as well as bottomline topped the Street's expectations in Q1 despite a high base....

Dr Reddy's rises to 52-week high as Q1 earnings top estimate; brokerages positive but valuations a sore point

11.43 am | 27 Jul 2023 |  Source: Moneycontrol.com

Dr Reddy's topline as well as bottomline topped the Street's expectations in Q1 despite a high base....

Dr Reddys Labs Consolidated June 2023 Net Sales at Rs 6,757.90 crore, up 29.14% Y-o-Y

9.44 am | 27 Jul 2023 |  Source: Moneycontrol.com

NULL...

Dr Reddy’s Q1 Results: Net profit rises 18% to Rs 1,402 crore, beats estimates

4.19 pm | 26 Jul 2023 |  Source: Moneycontrol.com

The Street had estimated a net profit of Rs 944.1 crore for the April-June quarter...

Dr Reddy's hits 52-week high as USFDA concludes PAI at Srikakulam unit with zero observations

9.30 am | 20 Jul 2023 |  Source: Moneycontrol.com

Another facility of Dr Reddy's in Srikakulam, focused on manufacturing formulations, was issued four observations by the US FDA during its inspect...

Dr Reddy’s rises 2% on plans to buy 26% stake in O2 Renewable Energy

10.26 am | 17 Jul 2023 |  Source: Moneycontrol.com

Shares of Dr Reddy's have risen over 22 percent year-to-date on the back of a strong momentum in the pharma sector, easing price erosion in the US...

USFDA accepts Dr Reddy's Biologics License Application for review; stock dips

9.46 am | 13 Jul 2023 |  Source: Moneycontrol.com

Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets....

Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang

12.24 pm | 12 Jul 2023 |  Source: Moneycontrol.com

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang....

Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang

12.24 pm | 12 Jul 2023 |  Source: Moneycontrol.com

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang....

Dr Reddy's to enhance presence in emerging segments like nutraceuticals, gene therapy

1.45 pm | 11 Jul 2023 |  Source: PTI

In its Annual Report for 2022-23, the Hyderabad-based drug major informed the shareholders that it also intends to follow a disciplined approach towar...

Buy Dr. Reddy’s Laboratories; target of Rs 5963: Sharekhan

12.24 pm | 05 Jul 2023 |  Source: Moneycontrol.com

Sharekhan is bullish on Dr. Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5963 in its research report dated...

Hot Stocks | Bet on Dr Reddy's Laboratories, Dabur India for short term

6.04 am | 26 Jun 2023 |  Source: Moneycontrol.com

For the bulls to regain control, the upward movement should start from the current levels....

Hold Dr. Reddy’s Laboratories; target of Rs 5100: Sharekhan

11.19 pm | 18 May 2023 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Dr. Reddy’s Laboratories with a target price of Rs 5100 in its research report dated May 17, 2023....

Buy Dr. Reddy’s Laboratories; target of Rs 5155: KR Choksey

10.41 pm | 14 May 2023 |  Source: Moneycontrol.com

KR Choksey is bullish on Dr. Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5155 in its research report date...

Reduce Dr. Reddy's Laboratories; target of Rs 4500: Prabhudas Lilladher

3.07 pm | 13 May 2023 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended Reduce rating on Dr. Reddy's Laboratories with a target price of Rs 4500 in its research report dated May 11, 2023...

Dr Reddys Labs Consolidated March 2023 Net Sales at Rs 6,315.20 crore, up 15.35% Y-o-Y

10.32 pm | 10 May 2023 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Standalone March 2023 Net Sales at Rs 4,554.00 crore, up 24.13% Y-o-Y

10.22 pm | 10 May 2023 |  Source: Moneycontrol.com

NULL...

Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals

5.27 pm | 10 May 2023 |  Source: Moneycontrol.com

Dr Reddy's bottomline also lagged the Street's estimate of Rs 1,093.6 crore....

Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher

7.44 pm | 29 Jan 2023 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Dr. Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 4900 in its research ...

Buy Dr Reddy's Laboratories; target of Rs 5210: ICICI Direct

7.08 pm | 29 Jan 2023 |  Source: Moneycontrol.com

ICICI Direct is bullish on Dr Reddy's Laboratories recommended buy rating on the stock with a target price of Rs 5210 in its research report dated...

1 2
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.